HOOK
Income statement / Annual
Last year (2023), HOOKIPA Pharma Inc.'s total revenue was $20.13 M,
an increase of 41.27% from the previous year.
In 2023, HOOKIPA Pharma Inc.'s net income was -$81.58 M.
See HOOKIPA Pharma Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$20.13 M
|
$14.25 M
|
$18.45 M
|
$19.58 M
|
$11.94 M
|
$7.63 M
|
$0.00
|
| Cost of Revenue |
$3.55 M |
$3.60 M |
$4.64 M |
$53.13 M |
$46.31 M |
$21.97 M |
$398,000.00 |
| Gross Profit |
$16.58 M |
$10.65 M |
$13.81 M |
-$33.55 M |
-$34.37 M |
-$14.34 M |
-$398,000.00 |
| Gross Profit Ratio |
0.82 |
0.75 |
0.75 |
-1.71 |
-2.88 |
-1.88 |
0 |
| Research and Development
Expenses |
$86.42 M
|
$68.65 M
|
$82.85 M
|
$54.79 M
|
$46.31 M
|
$21.97 M
|
$9.77 M
|
| General & Administrative
Expenses |
$18.63 M
|
$18.76 M
|
$17.27 M
|
$18.08 M
|
$16.72 M
|
$6.84 M
|
$4.39 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$18.63 M
|
$18.76 M
|
$17.27 M
|
$18.08 M
|
$16.72 M
|
$6.84 M
|
$4.39 M
|
| Other Expenses |
$0.00 |
-$392,000.00 |
-$2.84 M |
$3.07 M |
$601,000.00 |
$133,000.00 |
-$25,000.00 |
| Operating Expenses |
$32.75 M |
$87.40 M |
$100.12 M |
$72.87 M |
$63.03 M |
$23.20 M |
$12.09 M |
| Cost And Expenses |
$117.82 M |
$87.40 M |
$100.12 M |
$72.87 M |
$63.03 M |
$23.20 M |
$12.09 M |
| Interest Income |
$5.29 M |
$8.24 M |
$27,000.00 |
$9.20 M |
$1.59 M |
$0.00 |
$0.00 |
| Interest Expense |
$317,000.00 |
$687,000.00 |
$898,000.00 |
$786,000.00 |
$877,000.00 |
$778,000.00 |
$606,000.00 |
| Depreciation &
Amortization |
$3.55 M
|
$3.60 M
|
$4.64 M
|
$4.15 M
|
$3.07 M
|
$640,000.00
|
$398,000.00
|
| EBITDA |
-$77.34 M
|
-$60.40 M
|
-$70.13 M
|
-$39.15 M
|
-$39.09 M
|
-$14.80 M
|
-$13.76 M
|
| EBITDA Ratio |
-3.84 |
-5.13 |
-4.43 |
-2.72 |
-4.28 |
-1.94 |
0 |
| Operating Income Ratio
|
-4.85
|
-5.13
|
-4.43
|
-2.72
|
-4.28
|
-2.78
|
0
|
| Total Other
Income/Expenses Net |
$16.48 M
|
$8.47 M
|
$6.01 M
|
$9.20 M
|
$8.05 M
|
$4.97 M
|
$1.44 M
|
| Income Before Tax |
-$81.21 M |
-$64.92 M |
-$75.67 M |
-$44.08 M |
-$43.04 M |
-$16.21 M |
-$12.72 M |
| Income Before Tax Ratio
|
-4.03
|
-4.56
|
-4.1
|
-2.25
|
-3.6
|
-2.13
|
0
|
| Income Tax Expense |
$368,000.00 |
$230,000.00 |
$1,000.00 |
-$10.28 M |
-$8.89 M |
$24,000.00 |
$4,000.00 |
| Net Income |
-$81.58 M |
-$64.92 M |
-$75.67 M |
-$44.08 M |
-$43.04 M |
-$16.24 M |
-$12.72 M |
| Net Income Ratio |
-4.05 |
-4.56 |
-4.1 |
-2.25 |
-3.6 |
-2.13 |
0 |
| EPS |
-8.63 |
-9.9 |
-23 |
-16.9 |
-2.41 |
-0.99 |
-0.78 |
| EPS Diluted |
-8.63 |
-9.9 |
-23 |
-16.9 |
-2.41 |
-0.99 |
-0.78 |
| Weighted Average Shares
Out |
$9.45 M
|
$6.56 M
|
$3.29 M
|
$2.61 M
|
$17.86 M
|
$16.32 M
|
$16.32 M
|
| Weighted Average Shares
Out Diluted |
$9.45 M
|
$6.56 M
|
$3.29 M
|
$2.61 M
|
$17.86 M
|
$16.32 M
|
$16.32 M
|
| Link |
|
|
|
|
|
|
|
